Similar study has also demonstrated that SPOP-mutated prostate cancer cell lines and patient-derived organoids were intrinsically resistant to BET inhibitor-induced growth arrest and apoptosis (Dai et al., 2017). Here, SPOP is linked to prostate carcinoma.